Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Therapeutic Efficacy of the Combination Azithromycin + Ivermectin in the Treatment of Pediculosis in Senegal (IVERAZITH)

NCT03578679 is registered in ClinicalTrials.gov with Institut de Recherche pour le Developpement as lead sponsor.

NCT NCT03578679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03578679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Therapeutic Efficacy of the Combination Azithromycin + Ivermectin in the Treatment of Pediculosis in Senegal (IVERAZITH)
Lead sponsor
Institut de Recherche pour le Developpement
Phase
Not applicable
Overall status
Completed
Start date
July 11, 2018
Completion date
February 24, 2019
Enrollment
450 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediculoses